Global mRNA Therapy Market Research Report 2024, Forecast to 2032
Report Overview
By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.
The global mRNA Therapy market size was estimated at USD 36520 million in 2023 and is projected to reach USD 111467.59 million by 2032, exhibiting a CAGR of 13.20% during the forecast period.
North America mRNA Therapy market size was estimated at USD 11791.24 million in 2023, at a CAGR of 11.31% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global mRNA Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Therapy market in any manner.
Global mRNA Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Moderna
BioNTech
Pfizer
Arcturus Therapeutics Holdings Inc.
Astrazeneca
CureVac
Translate Bio
Regeneron Pharmaceuticals
Arcturus Therapeutics
Takeda Pharmaceutical Company
Novartis
Sanofi
Market Segmentation (by Type)
Vaccine
Drugs
Market Segmentation (by Application)
mRNA Targeted Delivery in vivo
Genetically Modified T cells
Transforming Nanoparticles to Develop Immunotherapy for Cancer
Small Molecule Drugs Discovery
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of mRNA Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.
The global mRNA Therapy market size was estimated at USD 36520 million in 2023 and is projected to reach USD 111467.59 million by 2032, exhibiting a CAGR of 13.20% during the forecast period.
North America mRNA Therapy market size was estimated at USD 11791.24 million in 2023, at a CAGR of 11.31% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global mRNA Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Therapy market in any manner.
Global mRNA Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Moderna
BioNTech
Pfizer
Arcturus Therapeutics Holdings Inc.
Astrazeneca
CureVac
Translate Bio
Regeneron Pharmaceuticals
Arcturus Therapeutics
Takeda Pharmaceutical Company
Novartis
Sanofi
Market Segmentation (by Type)
Vaccine
Drugs
Market Segmentation (by Application)
mRNA Targeted Delivery in vivo
Genetically Modified T cells
Transforming Nanoparticles to Develop Immunotherapy for Cancer
Small Molecule Drugs Discovery
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the mRNA Therapy Market
- Overview of the regional outlook of the mRNA Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of mRNA Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of mRNA Therapy
1.2 Key Market Segments
1.2.1 mRNA Therapy Segment by Type
1.2.2 mRNA Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global mRNA Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global mRNA Therapy Sales by Manufacturers (2019-2024)
3.2 Global mRNA Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global mRNA Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers mRNA Therapy Sales Sites, Area Served, Product Type
3.6 mRNA Therapy Market Competitive Situation and Trends
3.6.1 mRNA Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest mRNA Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MRNA THERAPY INDUSTRY CHAIN ANALYSIS
4.1 mRNA Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MRNA THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Therapy Sales Market Share by Type (2019-2024)
6.3 Global mRNA Therapy Market Size Market Share by Type (2019-2024)
6.4 Global mRNA Therapy Price by Type (2019-2024)
7 MRNA THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Therapy Market Sales by Application (2019-2024)
7.3 Global mRNA Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global mRNA Therapy Sales Growth Rate by Application (2019-2024)
8 MRNA THERAPY MARKET CONSUMPTION BY REGION
8.1 Global mRNA Therapy Sales by Region
8.1.1 Global mRNA Therapy Sales by Region
8.1.2 Global mRNA Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America mRNA Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe mRNA Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific mRNA Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America mRNA Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa mRNA Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 MRNA THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of mRNA Therapy by Region (2019-2024)
9.2 Global mRNA Therapy Revenue Market Share by Region (2019-2024)
9.3 Global mRNA Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America mRNA Therapy Production
9.4.1 North America mRNA Therapy Production Growth Rate (2019-2024)
9.4.2 North America mRNA Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe mRNA Therapy Production
9.5.1 Europe mRNA Therapy Production Growth Rate (2019-2024)
9.5.2 Europe mRNA Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan mRNA Therapy Production (2019-2024)
9.6.1 Japan mRNA Therapy Production Growth Rate (2019-2024)
9.6.2 Japan mRNA Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China mRNA Therapy Production (2019-2024)
9.7.1 China mRNA Therapy Production Growth Rate (2019-2024)
9.7.2 China mRNA Therapy Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Moderna
10.1.1 Moderna mRNA Therapy Basic Information
10.1.2 Moderna mRNA Therapy Product Overview
10.1.3 Moderna mRNA Therapy Product Market Performance
10.1.4 Moderna Business Overview
10.1.5 Moderna mRNA Therapy SWOT Analysis
10.1.6 Moderna Recent Developments
10.2 BioNTech
10.2.1 BioNTech mRNA Therapy Basic Information
10.2.2 BioNTech mRNA Therapy Product Overview
10.2.3 BioNTech mRNA Therapy Product Market Performance
10.2.4 BioNTech Business Overview
10.2.5 BioNTech mRNA Therapy SWOT Analysis
10.2.6 BioNTech Recent Developments
10.3 Pfizer
10.3.1 Pfizer mRNA Therapy Basic Information
10.3.2 Pfizer mRNA Therapy Product Overview
10.3.3 Pfizer mRNA Therapy Product Market Performance
10.3.4 Pfizer mRNA Therapy SWOT Analysis
10.3.5 Pfizer Business Overview
10.3.6 Pfizer Recent Developments
10.4 Arcturus Therapeutics Holdings Inc.
10.4.1 Arcturus Therapeutics Holdings Inc. mRNA Therapy Basic Information
10.4.2 Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Overview
10.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Market Performance
10.4.4 Arcturus Therapeutics Holdings Inc. Business Overview
10.4.5 Arcturus Therapeutics Holdings Inc. Recent Developments
10.5 Astrazeneca
10.5.1 Astrazeneca mRNA Therapy Basic Information
10.5.2 Astrazeneca mRNA Therapy Product Overview
10.5.3 Astrazeneca mRNA Therapy Product Market Performance
10.5.4 Astrazeneca Business Overview
10.5.5 Astrazeneca Recent Developments
10.6 CureVac
10.6.1 CureVac mRNA Therapy Basic Information
10.6.2 CureVac mRNA Therapy Product Overview
10.6.3 CureVac mRNA Therapy Product Market Performance
10.6.4 CureVac Business Overview
10.6.5 CureVac Recent Developments
10.7 Translate Bio
10.7.1 Translate Bio mRNA Therapy Basic Information
10.7.2 Translate Bio mRNA Therapy Product Overview
10.7.3 Translate Bio mRNA Therapy Product Market Performance
10.7.4 Translate Bio Business Overview
10.7.5 Translate Bio Recent Developments
10.8 Regeneron Pharmaceuticals
10.8.1 Regeneron Pharmaceuticals mRNA Therapy Basic Information
10.8.2 Regeneron Pharmaceuticals mRNA Therapy Product Overview
10.8.3 Regeneron Pharmaceuticals mRNA Therapy Product Market Performance
10.8.4 Regeneron Pharmaceuticals Business Overview
10.8.5 Regeneron Pharmaceuticals Recent Developments
10.9 Arcturus Therapeutics
10.9.1 Arcturus Therapeutics mRNA Therapy Basic Information
10.9.2 Arcturus Therapeutics mRNA Therapy Product Overview
10.9.3 Arcturus Therapeutics mRNA Therapy Product Market Performance
10.9.4 Arcturus Therapeutics Business Overview
10.9.5 Arcturus Therapeutics Recent Developments
10.10 Takeda Pharmaceutical Company
10.10.1 Takeda Pharmaceutical Company mRNA Therapy Basic Information
10.10.2 Takeda Pharmaceutical Company mRNA Therapy Product Overview
10.10.3 Takeda Pharmaceutical Company mRNA Therapy Product Market Performance
10.10.4 Takeda Pharmaceutical Company Business Overview
10.10.5 Takeda Pharmaceutical Company Recent Developments
10.11 Novartis
10.11.1 Novartis mRNA Therapy Basic Information
10.11.2 Novartis mRNA Therapy Product Overview
10.11.3 Novartis mRNA Therapy Product Market Performance
10.11.4 Novartis Business Overview
10.11.5 Novartis Recent Developments
10.12 Sanofi
10.12.1 Sanofi mRNA Therapy Basic Information
10.12.2 Sanofi mRNA Therapy Product Overview
10.12.3 Sanofi mRNA Therapy Product Market Performance
10.12.4 Sanofi Business Overview
10.12.5 Sanofi Recent Developments
11 MRNA THERAPY MARKET FORECAST BY REGION
11.1 Global mRNA Therapy Market Size Forecast
11.2 Global mRNA Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe mRNA Therapy Market Size Forecast by Country
11.2.3 Asia Pacific mRNA Therapy Market Size Forecast by Region
11.2.4 South America mRNA Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of mRNA Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global mRNA Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of mRNA Therapy by Type (2025-2032)
12.1.2 Global mRNA Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of mRNA Therapy by Type (2025-2032)
12.2 Global mRNA Therapy Market Forecast by Application (2025-2032)
12.2.1 Global mRNA Therapy Sales (K Units) Forecast by Application
12.2.2 Global mRNA Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of mRNA Therapy
1.2 Key Market Segments
1.2.1 mRNA Therapy Segment by Type
1.2.2 mRNA Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global mRNA Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global mRNA Therapy Sales by Manufacturers (2019-2024)
3.2 Global mRNA Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global mRNA Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers mRNA Therapy Sales Sites, Area Served, Product Type
3.6 mRNA Therapy Market Competitive Situation and Trends
3.6.1 mRNA Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest mRNA Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MRNA THERAPY INDUSTRY CHAIN ANALYSIS
4.1 mRNA Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MRNA THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Therapy Sales Market Share by Type (2019-2024)
6.3 Global mRNA Therapy Market Size Market Share by Type (2019-2024)
6.4 Global mRNA Therapy Price by Type (2019-2024)
7 MRNA THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Therapy Market Sales by Application (2019-2024)
7.3 Global mRNA Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global mRNA Therapy Sales Growth Rate by Application (2019-2024)
8 MRNA THERAPY MARKET CONSUMPTION BY REGION
8.1 Global mRNA Therapy Sales by Region
8.1.1 Global mRNA Therapy Sales by Region
8.1.2 Global mRNA Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America mRNA Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe mRNA Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific mRNA Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America mRNA Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa mRNA Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 MRNA THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of mRNA Therapy by Region (2019-2024)
9.2 Global mRNA Therapy Revenue Market Share by Region (2019-2024)
9.3 Global mRNA Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America mRNA Therapy Production
9.4.1 North America mRNA Therapy Production Growth Rate (2019-2024)
9.4.2 North America mRNA Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe mRNA Therapy Production
9.5.1 Europe mRNA Therapy Production Growth Rate (2019-2024)
9.5.2 Europe mRNA Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan mRNA Therapy Production (2019-2024)
9.6.1 Japan mRNA Therapy Production Growth Rate (2019-2024)
9.6.2 Japan mRNA Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China mRNA Therapy Production (2019-2024)
9.7.1 China mRNA Therapy Production Growth Rate (2019-2024)
9.7.2 China mRNA Therapy Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Moderna
10.1.1 Moderna mRNA Therapy Basic Information
10.1.2 Moderna mRNA Therapy Product Overview
10.1.3 Moderna mRNA Therapy Product Market Performance
10.1.4 Moderna Business Overview
10.1.5 Moderna mRNA Therapy SWOT Analysis
10.1.6 Moderna Recent Developments
10.2 BioNTech
10.2.1 BioNTech mRNA Therapy Basic Information
10.2.2 BioNTech mRNA Therapy Product Overview
10.2.3 BioNTech mRNA Therapy Product Market Performance
10.2.4 BioNTech Business Overview
10.2.5 BioNTech mRNA Therapy SWOT Analysis
10.2.6 BioNTech Recent Developments
10.3 Pfizer
10.3.1 Pfizer mRNA Therapy Basic Information
10.3.2 Pfizer mRNA Therapy Product Overview
10.3.3 Pfizer mRNA Therapy Product Market Performance
10.3.4 Pfizer mRNA Therapy SWOT Analysis
10.3.5 Pfizer Business Overview
10.3.6 Pfizer Recent Developments
10.4 Arcturus Therapeutics Holdings Inc.
10.4.1 Arcturus Therapeutics Holdings Inc. mRNA Therapy Basic Information
10.4.2 Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Overview
10.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Market Performance
10.4.4 Arcturus Therapeutics Holdings Inc. Business Overview
10.4.5 Arcturus Therapeutics Holdings Inc. Recent Developments
10.5 Astrazeneca
10.5.1 Astrazeneca mRNA Therapy Basic Information
10.5.2 Astrazeneca mRNA Therapy Product Overview
10.5.3 Astrazeneca mRNA Therapy Product Market Performance
10.5.4 Astrazeneca Business Overview
10.5.5 Astrazeneca Recent Developments
10.6 CureVac
10.6.1 CureVac mRNA Therapy Basic Information
10.6.2 CureVac mRNA Therapy Product Overview
10.6.3 CureVac mRNA Therapy Product Market Performance
10.6.4 CureVac Business Overview
10.6.5 CureVac Recent Developments
10.7 Translate Bio
10.7.1 Translate Bio mRNA Therapy Basic Information
10.7.2 Translate Bio mRNA Therapy Product Overview
10.7.3 Translate Bio mRNA Therapy Product Market Performance
10.7.4 Translate Bio Business Overview
10.7.5 Translate Bio Recent Developments
10.8 Regeneron Pharmaceuticals
10.8.1 Regeneron Pharmaceuticals mRNA Therapy Basic Information
10.8.2 Regeneron Pharmaceuticals mRNA Therapy Product Overview
10.8.3 Regeneron Pharmaceuticals mRNA Therapy Product Market Performance
10.8.4 Regeneron Pharmaceuticals Business Overview
10.8.5 Regeneron Pharmaceuticals Recent Developments
10.9 Arcturus Therapeutics
10.9.1 Arcturus Therapeutics mRNA Therapy Basic Information
10.9.2 Arcturus Therapeutics mRNA Therapy Product Overview
10.9.3 Arcturus Therapeutics mRNA Therapy Product Market Performance
10.9.4 Arcturus Therapeutics Business Overview
10.9.5 Arcturus Therapeutics Recent Developments
10.10 Takeda Pharmaceutical Company
10.10.1 Takeda Pharmaceutical Company mRNA Therapy Basic Information
10.10.2 Takeda Pharmaceutical Company mRNA Therapy Product Overview
10.10.3 Takeda Pharmaceutical Company mRNA Therapy Product Market Performance
10.10.4 Takeda Pharmaceutical Company Business Overview
10.10.5 Takeda Pharmaceutical Company Recent Developments
10.11 Novartis
10.11.1 Novartis mRNA Therapy Basic Information
10.11.2 Novartis mRNA Therapy Product Overview
10.11.3 Novartis mRNA Therapy Product Market Performance
10.11.4 Novartis Business Overview
10.11.5 Novartis Recent Developments
10.12 Sanofi
10.12.1 Sanofi mRNA Therapy Basic Information
10.12.2 Sanofi mRNA Therapy Product Overview
10.12.3 Sanofi mRNA Therapy Product Market Performance
10.12.4 Sanofi Business Overview
10.12.5 Sanofi Recent Developments
11 MRNA THERAPY MARKET FORECAST BY REGION
11.1 Global mRNA Therapy Market Size Forecast
11.2 Global mRNA Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe mRNA Therapy Market Size Forecast by Country
11.2.3 Asia Pacific mRNA Therapy Market Size Forecast by Region
11.2.4 South America mRNA Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of mRNA Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global mRNA Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of mRNA Therapy by Type (2025-2032)
12.1.2 Global mRNA Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of mRNA Therapy by Type (2025-2032)
12.2 Global mRNA Therapy Market Forecast by Application (2025-2032)
12.2.1 Global mRNA Therapy Sales (K Units) Forecast by Application
12.2.2 Global mRNA Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. mRNA Therapy Market Size Comparison by Region (M USD)
Table 5. Global mRNA Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global mRNA Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global mRNA Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global mRNA Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Therapy as of 2022)
Table 10. Global Market mRNA Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers mRNA Therapy Sales Sites and Area Served
Table 12. Manufacturers mRNA Therapy Product Type
Table 13. Global mRNA Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of mRNA Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Therapy Market Challenges
Table 22. Global mRNA Therapy Sales by Type (K Units)
Table 23. Global mRNA Therapy Market Size by Type (M USD)
Table 24. Global mRNA Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global mRNA Therapy Sales Market Share by Type (2019-2024)
Table 26. Global mRNA Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global mRNA Therapy Market Size Share by Type (2019-2024)
Table 28. Global mRNA Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global mRNA Therapy Sales (K Units) by Application
Table 30. Global mRNA Therapy Market Size by Application
Table 31. Global mRNA Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global mRNA Therapy Sales Market Share by Application (2019-2024)
Table 33. Global mRNA Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global mRNA Therapy Market Share by Application (2019-2024)
Table 35. Global mRNA Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global mRNA Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global mRNA Therapy Sales Market Share by Region (2019-2024)
Table 38. North America mRNA Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe mRNA Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific mRNA Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America mRNA Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa mRNA Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Global mRNA Therapy Production (K Units) by Region (2019-2024)
Table 44. Global mRNA Therapy Revenue (US$ Million) by Region (2019-2024)
Table 45. Global mRNA Therapy Revenue Market Share by Region (2019-2024)
Table 46. Global mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Moderna mRNA Therapy Basic Information
Table 52. Moderna mRNA Therapy Product Overview
Table 53. Moderna mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Moderna Business Overview
Table 55. Moderna mRNA Therapy SWOT Analysis
Table 56. Moderna Recent Developments
Table 57. BioNTech mRNA Therapy Basic Information
Table 58. BioNTech mRNA Therapy Product Overview
Table 59. BioNTech mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. BioNTech Business Overview
Table 61. BioNTech mRNA Therapy SWOT Analysis
Table 62. BioNTech Recent Developments
Table 63. Pfizer mRNA Therapy Basic Information
Table 64. Pfizer mRNA Therapy Product Overview
Table 65. Pfizer mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Pfizer mRNA Therapy SWOT Analysis
Table 67. Pfizer Business Overview
Table 68. Pfizer Recent Developments
Table 69. Arcturus Therapeutics Holdings Inc. mRNA Therapy Basic Information
Table 70. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Overview
Table 71. Arcturus Therapeutics Holdings Inc. mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Arcturus Therapeutics Holdings Inc. Business Overview
Table 73. Arcturus Therapeutics Holdings Inc. Recent Developments
Table 74. Astrazeneca mRNA Therapy Basic Information
Table 75. Astrazeneca mRNA Therapy Product Overview
Table 76. Astrazeneca mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Astrazeneca Business Overview
Table 78. Astrazeneca Recent Developments
Table 79. CureVac mRNA Therapy Basic Information
Table 80. CureVac mRNA Therapy Product Overview
Table 81. CureVac mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. CureVac Business Overview
Table 83. CureVac Recent Developments
Table 84. Translate Bio mRNA Therapy Basic Information
Table 85. Translate Bio mRNA Therapy Product Overview
Table 86. Translate Bio mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Translate Bio Business Overview
Table 88. Translate Bio Recent Developments
Table 89. Regeneron Pharmaceuticals mRNA Therapy Basic Information
Table 90. Regeneron Pharmaceuticals mRNA Therapy Product Overview
Table 91. Regeneron Pharmaceuticals mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Regeneron Pharmaceuticals Business Overview
Table 93. Regeneron Pharmaceuticals Recent Developments
Table 94. Arcturus Therapeutics mRNA Therapy Basic Information
Table 95. Arcturus Therapeutics mRNA Therapy Product Overview
Table 96. Arcturus Therapeutics mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Arcturus Therapeutics Business Overview
Table 98. Arcturus Therapeutics Recent Developments
Table 99. Takeda Pharmaceutical Company mRNA Therapy Basic Information
Table 100. Takeda Pharmaceutical Company mRNA Therapy Product Overview
Table 101. Takeda Pharmaceutical Company mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Takeda Pharmaceutical Company Business Overview
Table 103. Takeda Pharmaceutical Company Recent Developments
Table 104. Novartis mRNA Therapy Basic Information
Table 105. Novartis mRNA Therapy Product Overview
Table 106. Novartis mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Novartis Business Overview
Table 108. Novartis Recent Developments
Table 109. Sanofi mRNA Therapy Basic Information
Table 110. Sanofi mRNA Therapy Product Overview
Table 111. Sanofi mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Sanofi Business Overview
Table 113. Sanofi Recent Developments
Table 114. Global mRNA Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 115. Global mRNA Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America mRNA Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 117. North America mRNA Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe mRNA Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 119. Europe mRNA Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific mRNA Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 121. Asia Pacific mRNA Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America mRNA Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 123. South America mRNA Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa mRNA Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa mRNA Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global mRNA Therapy Sales Forecast by Type (2025-2032) & (K Units)
Table 127. Global mRNA Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global mRNA Therapy Price Forecast by Type (2025-2032) & (USD/Unit)
Table 129. Global mRNA Therapy Sales (K Units) Forecast by Application (2025-2032)
Table 130. Global mRNA Therapy Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. mRNA Therapy Market Size Comparison by Region (M USD)
Table 5. Global mRNA Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global mRNA Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global mRNA Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global mRNA Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Therapy as of 2022)
Table 10. Global Market mRNA Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers mRNA Therapy Sales Sites and Area Served
Table 12. Manufacturers mRNA Therapy Product Type
Table 13. Global mRNA Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of mRNA Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Therapy Market Challenges
Table 22. Global mRNA Therapy Sales by Type (K Units)
Table 23. Global mRNA Therapy Market Size by Type (M USD)
Table 24. Global mRNA Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global mRNA Therapy Sales Market Share by Type (2019-2024)
Table 26. Global mRNA Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global mRNA Therapy Market Size Share by Type (2019-2024)
Table 28. Global mRNA Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global mRNA Therapy Sales (K Units) by Application
Table 30. Global mRNA Therapy Market Size by Application
Table 31. Global mRNA Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global mRNA Therapy Sales Market Share by Application (2019-2024)
Table 33. Global mRNA Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global mRNA Therapy Market Share by Application (2019-2024)
Table 35. Global mRNA Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global mRNA Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global mRNA Therapy Sales Market Share by Region (2019-2024)
Table 38. North America mRNA Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe mRNA Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific mRNA Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America mRNA Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa mRNA Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Global mRNA Therapy Production (K Units) by Region (2019-2024)
Table 44. Global mRNA Therapy Revenue (US$ Million) by Region (2019-2024)
Table 45. Global mRNA Therapy Revenue Market Share by Region (2019-2024)
Table 46. Global mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Moderna mRNA Therapy Basic Information
Table 52. Moderna mRNA Therapy Product Overview
Table 53. Moderna mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Moderna Business Overview
Table 55. Moderna mRNA Therapy SWOT Analysis
Table 56. Moderna Recent Developments
Table 57. BioNTech mRNA Therapy Basic Information
Table 58. BioNTech mRNA Therapy Product Overview
Table 59. BioNTech mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. BioNTech Business Overview
Table 61. BioNTech mRNA Therapy SWOT Analysis
Table 62. BioNTech Recent Developments
Table 63. Pfizer mRNA Therapy Basic Information
Table 64. Pfizer mRNA Therapy Product Overview
Table 65. Pfizer mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Pfizer mRNA Therapy SWOT Analysis
Table 67. Pfizer Business Overview
Table 68. Pfizer Recent Developments
Table 69. Arcturus Therapeutics Holdings Inc. mRNA Therapy Basic Information
Table 70. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Overview
Table 71. Arcturus Therapeutics Holdings Inc. mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Arcturus Therapeutics Holdings Inc. Business Overview
Table 73. Arcturus Therapeutics Holdings Inc. Recent Developments
Table 74. Astrazeneca mRNA Therapy Basic Information
Table 75. Astrazeneca mRNA Therapy Product Overview
Table 76. Astrazeneca mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Astrazeneca Business Overview
Table 78. Astrazeneca Recent Developments
Table 79. CureVac mRNA Therapy Basic Information
Table 80. CureVac mRNA Therapy Product Overview
Table 81. CureVac mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. CureVac Business Overview
Table 83. CureVac Recent Developments
Table 84. Translate Bio mRNA Therapy Basic Information
Table 85. Translate Bio mRNA Therapy Product Overview
Table 86. Translate Bio mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Translate Bio Business Overview
Table 88. Translate Bio Recent Developments
Table 89. Regeneron Pharmaceuticals mRNA Therapy Basic Information
Table 90. Regeneron Pharmaceuticals mRNA Therapy Product Overview
Table 91. Regeneron Pharmaceuticals mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Regeneron Pharmaceuticals Business Overview
Table 93. Regeneron Pharmaceuticals Recent Developments
Table 94. Arcturus Therapeutics mRNA Therapy Basic Information
Table 95. Arcturus Therapeutics mRNA Therapy Product Overview
Table 96. Arcturus Therapeutics mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Arcturus Therapeutics Business Overview
Table 98. Arcturus Therapeutics Recent Developments
Table 99. Takeda Pharmaceutical Company mRNA Therapy Basic Information
Table 100. Takeda Pharmaceutical Company mRNA Therapy Product Overview
Table 101. Takeda Pharmaceutical Company mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Takeda Pharmaceutical Company Business Overview
Table 103. Takeda Pharmaceutical Company Recent Developments
Table 104. Novartis mRNA Therapy Basic Information
Table 105. Novartis mRNA Therapy Product Overview
Table 106. Novartis mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Novartis Business Overview
Table 108. Novartis Recent Developments
Table 109. Sanofi mRNA Therapy Basic Information
Table 110. Sanofi mRNA Therapy Product Overview
Table 111. Sanofi mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Sanofi Business Overview
Table 113. Sanofi Recent Developments
Table 114. Global mRNA Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 115. Global mRNA Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America mRNA Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 117. North America mRNA Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe mRNA Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 119. Europe mRNA Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific mRNA Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 121. Asia Pacific mRNA Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America mRNA Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 123. South America mRNA Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa mRNA Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa mRNA Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global mRNA Therapy Sales Forecast by Type (2025-2032) & (K Units)
Table 127. Global mRNA Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global mRNA Therapy Price Forecast by Type (2025-2032) & (USD/Unit)
Table 129. Global mRNA Therapy Sales (K Units) Forecast by Application (2025-2032)
Table 130. Global mRNA Therapy Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of mRNA Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Therapy Market Size (M USD), 2019-2032
Figure 5. Global mRNA Therapy Market Size (M USD) (2019-2032)
Figure 6. Global mRNA Therapy Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Therapy Market Size by Country (M USD)
Figure 11. mRNA Therapy Sales Share by Manufacturers in 2023
Figure 12. Global mRNA Therapy Revenue Share by Manufacturers in 2023
Figure 13. mRNA Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market mRNA Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by mRNA Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global mRNA Therapy Market Share by Type
Figure 18. Sales Market Share of mRNA Therapy by Type (2019-2024)
Figure 19. Sales Market Share of mRNA Therapy by Type in 2023
Figure 20. Market Size Share of mRNA Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of mRNA Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global mRNA Therapy Market Share by Application
Figure 24. Global mRNA Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global mRNA Therapy Sales Market Share by Application in 2023
Figure 26. Global mRNA Therapy Market Share by Application (2019-2024)
Figure 27. Global mRNA Therapy Market Share by Application in 2023
Figure 28. Global mRNA Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global mRNA Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America mRNA Therapy Sales Market Share by Country in 2023
Figure 32. U.S. mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada mRNA Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico mRNA Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe mRNA Therapy Sales Market Share by Country in 2023
Figure 37. Germany mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific mRNA Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific mRNA Therapy Sales Market Share by Region in 2023
Figure 44. China mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America mRNA Therapy Sales and Growth Rate (K Units)
Figure 50. South America mRNA Therapy Sales Market Share by Country in 2023
Figure 51. Brazil mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa mRNA Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa mRNA Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global mRNA Therapy Production Market Share by Region (2019-2024)
Figure 62. North America mRNA Therapy Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe mRNA Therapy Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan mRNA Therapy Production (K Units) Growth Rate (2019-2024)
Figure 65. China mRNA Therapy Production (K Units) Growth Rate (2019-2024)
Figure 66. Global mRNA Therapy Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global mRNA Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global mRNA Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global mRNA Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global mRNA Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global mRNA Therapy Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of mRNA Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Therapy Market Size (M USD), 2019-2032
Figure 5. Global mRNA Therapy Market Size (M USD) (2019-2032)
Figure 6. Global mRNA Therapy Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Therapy Market Size by Country (M USD)
Figure 11. mRNA Therapy Sales Share by Manufacturers in 2023
Figure 12. Global mRNA Therapy Revenue Share by Manufacturers in 2023
Figure 13. mRNA Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market mRNA Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by mRNA Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global mRNA Therapy Market Share by Type
Figure 18. Sales Market Share of mRNA Therapy by Type (2019-2024)
Figure 19. Sales Market Share of mRNA Therapy by Type in 2023
Figure 20. Market Size Share of mRNA Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of mRNA Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global mRNA Therapy Market Share by Application
Figure 24. Global mRNA Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global mRNA Therapy Sales Market Share by Application in 2023
Figure 26. Global mRNA Therapy Market Share by Application (2019-2024)
Figure 27. Global mRNA Therapy Market Share by Application in 2023
Figure 28. Global mRNA Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global mRNA Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America mRNA Therapy Sales Market Share by Country in 2023
Figure 32. U.S. mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada mRNA Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico mRNA Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe mRNA Therapy Sales Market Share by Country in 2023
Figure 37. Germany mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific mRNA Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific mRNA Therapy Sales Market Share by Region in 2023
Figure 44. China mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America mRNA Therapy Sales and Growth Rate (K Units)
Figure 50. South America mRNA Therapy Sales Market Share by Country in 2023
Figure 51. Brazil mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa mRNA Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa mRNA Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa mRNA Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global mRNA Therapy Production Market Share by Region (2019-2024)
Figure 62. North America mRNA Therapy Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe mRNA Therapy Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan mRNA Therapy Production (K Units) Growth Rate (2019-2024)
Figure 65. China mRNA Therapy Production (K Units) Growth Rate (2019-2024)
Figure 66. Global mRNA Therapy Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global mRNA Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global mRNA Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global mRNA Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global mRNA Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global mRNA Therapy Market Share Forecast by Application (2025-2032)
